{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T05:20:58Z","timestamp":1794979258006,"version":"4.9.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T00:00:00Z","timestamp":1656547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T00:00:00Z","timestamp":1656547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cell Biol"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1038\/s41556-022-00942-8","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T12:20:56Z","timestamp":1656591656000},"page":"1165-1176","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Dapl1 controls NFATc2 activation to regulate CD8+ T cell exhaustion and responses in chronic infection and cancer"],"prefix":"10.1038","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1732-8753","authenticated-orcid":false,"given":"Lele","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meidi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiseong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanchuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Jung","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxiao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7353-9400","authenticated-orcid":false,"given":"Shao-Cong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,30]]},"reference":[{"key":"942_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.immuni.2011.07.010","volume":"35","author":"N Zhang","year":"2011","unstructured":"Zhang, N. & Bevan, M. J. CD8+ T cells: foot soldiers of the immune system. Immunity 35, 161\u2013168 (2011).","journal-title":"Immunity"},{"key":"942_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fimmu.2018.00014","volume":"9","author":"A Durgeau","year":"2018","unstructured":"Durgeau, A., Virk, Y., Corgnac, S. & Mami-Chouaib, F. Recent advances in targeting CD8 T-cell immunity for more effective cancer immunotherapy. Front. Immunol. 9, 14 (2018).","journal-title":"Front. Immunol"},{"key":"942_CR3","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1146\/annurev-med-012017-043208","volume":"69","author":"M Hashimoto","year":"2018","unstructured":"Hashimoto, M. et al. CD8 T cell exhaustion in chronic infection and cancer: opportunities for interventions. Annu. Rev. Med. 69, 301\u2013318 (2018).","journal-title":"Annu. Rev. Med."},{"key":"942_CR4","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","volume":"37","author":"LM McLane","year":"2019","unstructured":"McLane, L. M., Abdel-Hakeem, M. S. & Wherry, E. J. CD8 T cell exhaustion during chronic viral infection and cancer. Annu. Rev. Immunol. 37, 457\u2013495 (2019).","journal-title":"Annu. Rev. Immunol."},{"key":"942_CR5","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41568-019-0235-4","volume":"20","author":"AM van der Leun","year":"2020","unstructured":"van der Leun, A. M., Thommen, D. S. & Schumacher, T. N. CD8+ T cell states in human cancer: insights from single-cell analysis. Nat. Rev. Cancer 20, 218\u2013232 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"942_CR6","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll, D. M. The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer 12, 252\u2013264 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"942_CR7","doi-asserted-by":"publisher","first-page":"328rv324","DOI":"10.1126\/scitranslmed.aad7118","volume":"8","author":"W Zou","year":"2016","unstructured":"Zou, W., Wolchok, J. D. & Chen, L. PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: mechanisms, response biomarkers, and combinations. Sci. Transl. Med. 8, 328rv324 (2016).","journal-title":"Sci. Transl. Med."},{"key":"942_CR8","doi-asserted-by":"publisher","first-page":"6505","DOI":"10.2147\/OTT.S150817","volume":"11","author":"E Grywalska","year":"2018","unstructured":"Grywalska, E., Pasiarski, M., Gozdz, S. & Rolinski, J. Immune-checkpoint inhibitors for combating T-cell dysfunction in cancer. OncoTargets Ther. 11, 6505\u20136524 (2018).","journal-title":"OncoTargets Ther."},{"key":"942_CR9","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","volume":"20","author":"BC Miller","year":"2019","unstructured":"Miller, B. C. et al. Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade. Nat. Immunol. 20, 326\u2013336 (2019).","journal-title":"Nat. Immunol."},{"key":"942_CR10","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2018.11.043","volume":"176","author":"H Li","year":"2019","unstructured":"Li, H. et al. Dysfunctional CD8 T cells form a proliferative, dynamically regulated compartment within human melanoma. Cell 176, 775\u2013789 (2019).","journal-title":"Cell"},{"key":"942_CR11","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41577-019-0223-7","volume":"20","author":"A Kallies","year":"2020","unstructured":"Kallies, A., Zehn, D. & Utzschneider, D. T. Precursor exhausted T cells: key to successful immunotherapy? Nat. Rev. Immunol. 20, 128\u2013136 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"942_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","volume":"50","author":"I Siddiqui","year":"2019","unstructured":"Siddiqui, I. et al. Intratumoral Tcf1+PD-1+CD8+ T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy. Immunity 50, 195\u2013211 (2019).","journal-title":"Immunity"},{"key":"942_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.immuni.2018.11.014","volume":"50","author":"S Kurtulus","year":"2019","unstructured":"Kurtulus, S. et al. Checkpoint blockade immunotherapy induces dynamic changes in PD-1\u2212CD8+ tumor-infiltrating T cells. Immunity 50, 181\u2013194 (2019).","journal-title":"Immunity"},{"key":"942_CR14","doi-asserted-by":"crossref","unstructured":"Escobar, G., Mangani, D. & Anderson, A. C. T cell factor 1: a master regulator of the T cell response in disease. Sci. Immunol. 5, eabb9726 (2020).","DOI":"10.1126\/sciimmunol.abb9726"},{"key":"942_CR15","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.immuni.2016.07.021","volume":"45","author":"DT Utzschneider","year":"2016","unstructured":"Utzschneider, D. T. et al. T cell factor 1-expressing memory-like CD8+ T cells sustain the immune response to chronic viral infections. Immunity 45, 415\u2013427 (2016).","journal-title":"Immunity"},{"key":"942_CR16","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.immuni.2020.04.014","volume":"52","author":"JC Beltra","year":"2020","unstructured":"Beltra, J. C. et al. Developmental relationships of four exhausted CD8+ T cell subsets reveals underlying transcriptional and epigenetic landscape control mechanisms. Immunity 52, 825\u2013841 (2020).","journal-title":"Immunity"},{"key":"942_CR17","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.immuni.2017.11.021","volume":"47","author":"K Man","year":"2017","unstructured":"Man, K. et al. Transcription factor IRF4 promotes CD8+ T cell exhaustion and limits the development of memory-like T cells during chronic infection. Immunity 47, 1129\u20131141 (2017).","journal-title":"Immunity"},{"key":"942_CR18","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.immuni.2015.01.006","volume":"42","author":"GJ Martinez","year":"2015","unstructured":"Martinez, G. J. et al. The transcription factor NFAT promotes exhaustion of activated CD8+ T cells. Immunity 42, 265\u2013278 (2015).","journal-title":"Immunity"},{"key":"942_CR19","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s12276-021-00568-0","volume":"53","author":"W Seo","year":"2021","unstructured":"Seo, W., Jerin, C. & Nishikawa, H. Transcriptional regulatory network for the establishment of CD8+ T cell exhaustion. Exp. Mol. Med. 53, 202\u2013209 (2021).","journal-title":"Exp. Mol. Med."},{"key":"942_CR20","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","volume":"27","author":"EJ Wherry","year":"2007","unstructured":"Wherry, E. J. et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27, 670\u2013684 (2007).","journal-title":"Immunity"},{"key":"942_CR21","doi-asserted-by":"publisher","first-page":"15019","DOI":"10.1073\/pnas.1309378110","volume":"110","author":"F Raczkowski","year":"2013","unstructured":"Raczkowski, F. et al. The transcription factor interferon regulatory factor 4 is required for the generation of protective effector CD8+ T cells. Proc. Natl Acad. Sci. USA 110, 15019\u201315024 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"942_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00612-6","volume":"8","author":"S Klein-Hessling","year":"2017","unstructured":"Klein-Hessling, S. et al. NFATc1 controls the cytotoxicity of CD8+ T cells. Nat. Commun. 8, 511 (2017).","journal-title":"Nat. Commun."},{"key":"942_CR23","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1126\/science.1090148","volume":"302","author":"EL Pearce","year":"2003","unstructured":"Pearce, E. L. et al. Control of effector CD8+ T cell function by the transcription factor eomesodermin. Science 302, 1041\u20131043 (2003).","journal-title":"Science"},{"key":"942_CR24","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1093\/hmg\/ddx063","volume":"26","author":"X Ma","year":"2017","unstructured":"Ma, X. et al. DAPL1, a susceptibility locus for age-related macular degeneration, acts as a novel suppressor of cell proliferation in the retinal pigment epithelium. Hum. Mol. Genet. 26, 1612\u20131621 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"942_CR25","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/s41590-019-0405-2","volume":"20","author":"X Zhou","year":"2019","unstructured":"Zhou, X. et al. The deubiquitinase Otub1 controls the activation of CD8+ T cells and NK cells by regulating IL-15-mediated priming. Nat. Immunol. 20, 879\u2013889 (2019).","journal-title":"Nat. Immunol."},{"key":"942_CR26","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00281-015-0477-5","volume":"37","author":"SH Khan","year":"2015","unstructured":"Khan, S. H. & Badovinac, V. P. Listeria monocytogenes: a model pathogen to study antigen-specific memory CD8 T cell responses. Semin. Immunopathol. 37, 301\u2013310 (2015).","journal-title":"Semin. Immunopathol."},{"key":"942_CR27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3390\/pathogens7020055","volume":"7","author":"Z Qiu","year":"2018","unstructured":"Qiu, Z., Khairallah, C. & Sheridan, B. S. Listeria monocytogenes: a model pathogen continues to refine our knowledge of the CD8 T cell response. Pathogens 7, 55 (2018).","journal-title":"Pathogens"},{"key":"942_CR28","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1084\/jem.20030590","volume":"198","author":"WW Overwijk","year":"2003","unstructured":"Overwijk, W. W. et al. Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells. J. Exp. Med. 198, 569\u2013580 (2003).","journal-title":"J. Exp. Med."},{"key":"942_CR29","doi-asserted-by":"publisher","first-page":"eaai8593","DOI":"10.1126\/sciimmunol.aai8593","volume":"1","author":"T Wu","year":"2016","unstructured":"Wu, T. et al. The TCF1\u2013Bcl6 axis counteracts type I interferon to repress exhaustion and maintain T cell stemness. Sci. Immunol. 1, eaai8593 (2016).","journal-title":"Sci. Immunol."},{"key":"942_CR30","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.immuni.2019.09.013","volume":"51","author":"Z Chen","year":"2019","unstructured":"Chen, Z. et al. TCF-1-centered transcriptional network drives an effector versus exhausted CD8 T cell-fate decision. Immunity 51, 840\u2013855 (2019).","journal-title":"Immunity"},{"key":"942_CR31","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.immuni.2019.11.002","volume":"51","author":"WH Hudson","year":"2019","unstructured":"Hudson, W. H. et al. Proliferating transitory T cells with an effector-like transcriptional signature emerge from PD-1+ stem-like CD8+ T cells during chronic infection. Immunity 51, 1043\u20131058 (2019).","journal-title":"Immunity"},{"key":"942_CR32","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.immuni.2019.10.009","volume":"51","author":"R Zander","year":"2019","unstructured":"Zander, R. et al. CD4+ T cell help is required for the formation of a cytolytic CD8+ T cell subset that protects against chronic infection and cancer. Immunity 51, 1028\u20131042 (2019).","journal-title":"Immunity"},{"key":"942_CR33","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.4049\/jimmunol.155.4.1873","volume":"155","author":"TL Walunas","year":"1995","unstructured":"Walunas, T. L., Bruce, D. S., Dustin, L., Loh, D. Y. & Bluestone, J. A. Ly-6C is a marker of memory CD8+ T cells. J Immunol 155, 1873\u20131883 (1995).","journal-title":"J Immunol"},{"key":"942_CR34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4049\/jimmunol.161.1.97","volume":"161","author":"A Cerwenka","year":"1998","unstructured":"Cerwenka, A., Carter, L. L., Reome, J. B., Swain, S. L. & Dutton, R. W. In vivo persistence of CD8 polarized T cell subsets producing type 1 or type 2 cytokines. J. Immunol. 161, 97\u2013105 (1998).","journal-title":"J. Immunol."},{"key":"942_CR35","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.4049\/jimmunol.160.7.3236","volume":"160","author":"JM Curtsinger","year":"1998","unstructured":"Curtsinger, J. M., Lins, D. C. & Mescher, M. F. CD8+ memory T cells (CD44high, Ly-6C+) are more sensitive than naive cells to (CD44low, Ly-6C\u2212) to TCR\/CD8 signaling in response to antigen. J. Immunol. 160, 3236\u20133243 (1998).","journal-title":"J. Immunol."},{"key":"942_CR36","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/nri2818","volume":"10","author":"MR Muller","year":"2010","unstructured":"Muller, M. R. & Rao, A. NFAT, immunity and cancer: a transcription factor comes of age. Nat. Rev. Immunol. 10, 645\u2013656 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"942_CR37","doi-asserted-by":"publisher","first-page":"260","DOI":"10.12688\/f1000research.13426.1","volume":"7","author":"M Vaeth","year":"2018","unstructured":"Vaeth, M. & Feske, S. NFAT control of immune function: new frontiers for an abiding trooper. F1000Res. 7, 260 (2018).","journal-title":"F1000Res."},{"key":"942_CR38","doi-asserted-by":"publisher","first-page":"e47868","DOI":"10.1371\/journal.pone.0047868","volume":"7","author":"DV Faget","year":"2012","unstructured":"Faget, D. V., Lucena, P. I., Robbs, B. K. & Viola, J. P. NFAT1 C-terminal domains are necessary but not sufficient for inducing cell death. PLoS ONE 7, e47868 (2012).","journal-title":"PLoS ONE"},{"key":"942_CR39","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1128\/MCB.16.7.3945","volume":"16","author":"C Loh","year":"1996","unstructured":"Loh, C., Carew, J. A., Kim, J., Hogan, P. G. & Rao, A. T-cell receptor stimulation elicits an early phase of activation and a later phase of deactivation of the transcription factor NFAT1. Mol. Cell. Biol. 16, 3945\u20133954 (1996).","journal-title":"Mol. Cell. Biol."},{"key":"942_CR40","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/ni.2113","volume":"12","author":"Z Liu","year":"2011","unstructured":"Liu, Z. et al. The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease. Nat. Immunol. 12, 1063\u20131070 (2011).","journal-title":"Nat. Immunol."},{"key":"942_CR41","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ceca.2017.01.014","volume":"63","author":"PG Hogan","year":"2017","unstructured":"Hogan, P. G. Calcium-NFAT transcriptional signalling in T cell activation and T cell exhaustion. Cell Calcium 63, 66\u201369 (2017).","journal-title":"Cell Calcium"},{"key":"942_CR42","doi-asserted-by":"publisher","first-page":"1737369","DOI":"10.1080\/2162402X.2020.1737369","volume":"9","author":"SJ Carmona","year":"2020","unstructured":"Carmona, S. J., Siddiqui, I., Bilous, M., Held, W. & Gfeller, D. Deciphering the transcriptomic landscape of tumor-infiltrating CD8 lymphocytes in B16 melanoma tumors with single-cell RNA-seq. Oncoimmunology 9, 1737369 (2020).","journal-title":"Oncoimmunology"},{"key":"942_CR43","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3389\/fimmu.2019.00169","volume":"10","author":"Y Wang","year":"2019","unstructured":"Wang, Y. et al. The transcription factor TCF1 preserves the effector function of exhausted CD8 T cells during chronic viral infection. Front. Immunol. 10, 169 (2019).","journal-title":"Front. Immunol."},{"key":"942_CR44","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1084\/jem.20100643","volume":"207","author":"K Sakuishi","year":"2010","unstructured":"Sakuishi, K. et al. Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J. Exp. Med. 207, 2187\u20132194 (2010).","journal-title":"J. Exp. Med."},{"key":"942_CR45","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/ni1315","volume":"7","author":"WW Reiley","year":"2006","unstructured":"Reiley, W. W. et al. Regulation of T cell development by the deubiquitinating enzyme CYLD. Nat. Immunol. 7, 411\u2013417 (2006).","journal-title":"Nat. Immunol."},{"key":"942_CR46","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1084\/jem.20062694","volume":"204","author":"WW Reiley","year":"2007","unstructured":"Reiley, W. W. et al. Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T cell responses. J. Exp. Med. 204, 1475\u20131485 (2007).","journal-title":"J. Exp. Med."},{"key":"942_CR47","doi-asserted-by":"publisher","first-page":"e935","DOI":"10.1371\/journal.pone.0000935","volume":"2","author":"M Podtschaske","year":"2007","unstructured":"Podtschaske, M. et al. Digital NFATc2 activation per cell transforms graded T cell receptor activation into an all-or-none IL-2 expression. PLoS ONE 2, e935 (2007).","journal-title":"PLoS ONE"},{"key":"942_CR48","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1084\/jem.160.2.521","volume":"160","author":"R Ahmed","year":"1984","unstructured":"Ahmed, R., Salmi, A., Butler, L. D., Chiller, J. M. & Oldstone, M. B. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J. Exp. Med. 160, 521\u2013540 (1984).","journal-title":"J. Exp. Med."},{"key":"942_CR49","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nprot.2006.27","volume":"1","author":"JD Nelson","year":"2006","unstructured":"Nelson, J. D., Denisenko, O. & Bomsztyk, K. Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nat. Protoc. 1, 179\u2013185 (2006).","journal-title":"Nat. Protoc."},{"key":"942_CR50","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S1097-2765(01)00187-3","volume":"7","author":"G Xiao","year":"2001","unstructured":"Xiao, G., Harhaj, E. W. & Sun, S. C. NF-\u03baB-inducing kinase regulates the processing of NF-\u03baB2 p100. Mol. Cell 7, 401\u2013409 (2001).","journal-title":"Mol. Cell"},{"key":"942_CR51","doi-asserted-by":"publisher","first-page":"e1008555","DOI":"10.1371\/journal.ppat.1008555","volume":"16","author":"M Zhao","year":"2020","unstructured":"Zhao, M. et al. Rapid in vitro generation of bona fide exhausted CD8+ T cells is accompanied by Tcf7 promotor methylation. PLoS Pathog. 16, e1008555 (2020).","journal-title":"PLoS Pathog."},{"key":"942_CR52","doi-asserted-by":"crossref","unstructured":"Dunsford, L. S., Thoirs, R. H., Rathbone, E. & Patakas, A. in Immuno-Oncology (ed. Tan, S.-L.) 89\u2013101 (Humana New York, 2020).","DOI":"10.1007\/978-1-0716-0171-6_6"}],"container-title":["Nature Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41556-022-00942-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41556-022-00942-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41556-022-00942-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T02:24:33Z","timestamp":1675995873000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41556-022-00942-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,30]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["942"],"URL":"https:\/\/doi.org\/10.1038\/s41556-022-00942-8","relation":{},"ISSN":["1465-7392","1476-4679"],"issn-type":[{"value":"1465-7392","type":"print"},{"value":"1476-4679","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,30]]},"assertion":[{"value":"11 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Although they participated in this research while employed in the University of Texas MD Anderson Cancer Center, X.Z. is presently an employee of Flagship Labs 91, Inc, J.K. is presently an employee of Bristol Myers Squibb and X.X. is presently an employee of AbbVie. All competing interests are unrelated to the current study. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}